| Adolph Isom, MD | |
|
3280 Dauphin St, Building B, Suite 118, Mobile, AL 36606-4060 | |
| (251) 454-4579 | |
| (251) 287-1466 |
| Full Name | Adolph Isom |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 48 Years |
| Location | 3280 Dauphin St, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003996521 | NPI | - | NPPES |
| 009933259 | Medicaid | AL | |
| 009936127 | Medicaid | AL | |
| 009936128 | Medicaid | AL | |
| 009936129 | Medicaid | AL | |
| 146753 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD.14341 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Imc-hospitalists Llc | 2264727155 | 66 |
News Archive
In this post in the Huffington Post's "Impact" blog, Sheila Nix, executive director of ONE in the U.S., summarizes progress in the global fight against HIV/AIDS in the 30 years since the first cases were documented and writes that "as budgets constrict and leaders turn their attention inward, it's easy to see why a renewed push on global AIDS doesn't seem possible. Yet 2011 marks a critical inflection point in our fight against AIDS."
A new scientific statement issued today by the American Heart Association underscores the commonalities between cardiovascular disease and breast cancer among women, and it calls for more focus on research and specialized treatment where the diseases overlap.
British Prime Minister Tony Blair has virtually given the food and drinks industry in the UK an ultimatum saying unless the "junk food" industry can sort itself out it will be forced to restrict advertising to children next year.
ARCA biopharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of GencaroTM, the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator, for the reduction of cardiovascular mortality and cardiovascular hospitalizations in a genotype-defined heart failure population.
› Verified 7 days ago
| Entity Name | Inpatient Consultants Of Alabama, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235238916 PECOS PAC ID: 6709983422 Enrollment ID: O20110805000011 |
News Archive
In this post in the Huffington Post's "Impact" blog, Sheila Nix, executive director of ONE in the U.S., summarizes progress in the global fight against HIV/AIDS in the 30 years since the first cases were documented and writes that "as budgets constrict and leaders turn their attention inward, it's easy to see why a renewed push on global AIDS doesn't seem possible. Yet 2011 marks a critical inflection point in our fight against AIDS."
A new scientific statement issued today by the American Heart Association underscores the commonalities between cardiovascular disease and breast cancer among women, and it calls for more focus on research and specialized treatment where the diseases overlap.
British Prime Minister Tony Blair has virtually given the food and drinks industry in the UK an ultimatum saying unless the "junk food" industry can sort itself out it will be forced to restrict advertising to children next year.
ARCA biopharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of GencaroTM, the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator, for the reduction of cardiovascular mortality and cardiovascular hospitalizations in a genotype-defined heart failure population.
› Verified 7 days ago
| Entity Name | Imc-hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669824934 PECOS PAC ID: 2264727155 Enrollment ID: O20160816002233 |
News Archive
In this post in the Huffington Post's "Impact" blog, Sheila Nix, executive director of ONE in the U.S., summarizes progress in the global fight against HIV/AIDS in the 30 years since the first cases were documented and writes that "as budgets constrict and leaders turn their attention inward, it's easy to see why a renewed push on global AIDS doesn't seem possible. Yet 2011 marks a critical inflection point in our fight against AIDS."
A new scientific statement issued today by the American Heart Association underscores the commonalities between cardiovascular disease and breast cancer among women, and it calls for more focus on research and specialized treatment where the diseases overlap.
British Prime Minister Tony Blair has virtually given the food and drinks industry in the UK an ultimatum saying unless the "junk food" industry can sort itself out it will be forced to restrict advertising to children next year.
ARCA biopharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of GencaroTM, the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator, for the reduction of cardiovascular mortality and cardiovascular hospitalizations in a genotype-defined heart failure population.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adolph Isom, MD Po Box 51254, Los Angeles, CA 90051-5554 Ph: (314) 317-0600 | Adolph Isom, MD 3280 Dauphin St, Building B, Suite 118, Mobile, AL 36606-4060 Ph: (251) 454-4579 |
News Archive
In this post in the Huffington Post's "Impact" blog, Sheila Nix, executive director of ONE in the U.S., summarizes progress in the global fight against HIV/AIDS in the 30 years since the first cases were documented and writes that "as budgets constrict and leaders turn their attention inward, it's easy to see why a renewed push on global AIDS doesn't seem possible. Yet 2011 marks a critical inflection point in our fight against AIDS."
A new scientific statement issued today by the American Heart Association underscores the commonalities between cardiovascular disease and breast cancer among women, and it calls for more focus on research and specialized treatment where the diseases overlap.
British Prime Minister Tony Blair has virtually given the food and drinks industry in the UK an ultimatum saying unless the "junk food" industry can sort itself out it will be forced to restrict advertising to children next year.
ARCA biopharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of GencaroTM, the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator, for the reduction of cardiovascular mortality and cardiovascular hospitalizations in a genotype-defined heart failure population.
› Verified 7 days ago
Miss Carmen Lopez, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1700 Spring Hill Ave Ste 100, Mobile, AL 36604 Phone: 251-435-1200 | |
Dhruv Vasant, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-435-7289 Fax: 251-435-1616 | |
Dr. James Nelson Byrd Jr., MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Mobile, AL 36607 Phone: 251-435-7289 Fax: 251-435-7282 | |
Frankie Wendell Erdman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5 Mobile Infirmary Cir, Pob Suite 308, Mobile, AL 36607 Phone: 251-435-7223 Fax: 251-435-7282 | |
Michael Claude Lysek Jr., M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2451 Usa Medical Center Dr, Mobile, AL 36617 Phone: 251-471-7000 | |
Anna Foust, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2451 University Hospital Dr, Mobile, AL 36617 Phone: 251-471-7891 Fax: 251-470-1652 |